Reaction Details Report a problem with these data
Target
Integrase
Ligand
BDBM294659
Substrate
n/a
Meas. Tech.
Anti-HIV Activity MT4 Assay
IC50
2.00±n/a nM
Citation
 Johns, BA; Velthuisen, EJ; Weatherhead, JG; Suwandi, L; Temelkoff, D Isoindoline derivatives for use in the treatment of a viral infection US Patent  US10112899 Publication Date 10/30/2018 
Target
Name:
Integrase
Synonyms:
Human immunodeficiency virus type 1 integrase
Type:
PROTEIN
Mol. Mass.:
32231.48
Organism:
Human immunodeficiency virus 1
Description:
ChEMBL_90865
Residue:
288
Sequence:
FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED
  
Inhibitor
Name:
BDBM294659
Synonyms:
US10112899, Example 138
Type:
Small organic molecule
Emp. Form.:
C34H36FNO7
Mol. Mass.:
589.6505
SMILES:
Cc1c2CN(Cc2c(C)c(-c2cc(F)c3OCCCc3c2C)c1[C@H](OC(C)(C)C)C(O)=O)C(=O)c1cccc2OCOc12 |r,wD:23.27,(3.62,-1.65,;2.29,-.88,;.95,-1.65,;.63,-3.16,;-.9,-3.32,;-1.52,-1.91,;-.38,-.88,;-.38,.66,;-1.71,1.43,;.95,1.43,;.95,2.97,;2.29,3.74,;2.29,5.28,;3.62,6.05,;.95,6.05,;.95,7.59,;-.38,8.36,;-1.71,7.59,;-1.71,6.05,;-.38,5.28,;-.38,3.74,;-1.71,2.97,;2.29,.66,;3.62,1.43,;3.62,2.97,;4.95,3.74,;4.95,5.28,;6.29,2.97,;6.29,4.51,;4.95,.66,;6.29,1.43,;4.95,-.88,;-1.67,-4.65,;-.9,-5.99,;-3.21,-4.65,;-3.98,-3.32,;-5.52,-3.32,;-6.29,-4.65,;-5.52,-5.99,;-5.99,-7.45,;-4.75,-8.36,;-3.5,-7.45,;-3.98,-5.99,)|
Structure:
Search PDB for entries with ligand similarity: